Related Experiment Video
Updated: Jun 5, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
[Adverse effects of the human papillomavirus vaccine]
M Amparo Torrecilla Rojas1, Miguel Pedregal González, Fermín García Rodríguez
1Distrito Condado-Campiña, Huelva, Spain. amparotorrecilla@andaluciajunta.es
Objective:
To describe the most frequent adverse reactions produced by the human papillomavirus (HPV) vaccine.
Design:
Cross-sectional descriptive study using a telephone survey.
Setting:
A province in the Andalusian Public Health System.
Participants:
Females vaccinated against HPV in Andalusia, selected by simple random sampling representative of the province.
Main Measurements:
A total of 3,135 telephone calls were made by the public service "Health Answers" using telephone operators supervised by health personnel.
Results:
Of the 2,880 calls that fulfilled the inclusion criteria, 1,207 people (41.9% response) took part in the survey. Of the 2,124 surveys made there was some type of adverse reaction (fever, inflammation, pain or rash) in 467 doses (22%): 6.6% was fever, 49.5% inflammation, 72.4% pain, and 6% a rash.
Conclusions:
It can be said that HPV vaccine is safe, which is in agreement with that published in the summary of the product characteristics and in the literature.
Related Concept Videos
Vaccinations
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Genital Herpes
Chickenpox
Poliomyelitis
Vaccines
